IGIV is a concentrate of antibodies
purified from plasma taken from carefully screened donors.
Plasma is the pale yellow liquid portion of your blood that can
be easily replaced by the body. It consists mainly of water and
proteins, which help your body control bleeding and infection.
The plasma functions as an aid in the circulation of red and
white blood cells and platelets. It also makes possible natural
chemical communication among different parts of the body by carrying
minerals, hormones, vitamins, and antibodies.
It is important to know that plasma is not a substance that can
be produced in a laboratory or some other artificial environment.
It can only be obtained from healthy adults who donate plasma.
Donated plasma may be processed into a wide variety of products
used in the treatment of serious disorders such as hemophilia
and immune system deficiencies, and to make therapies used to
help treat and prevent diseases like tetanus, rabies, measles,
rubella and hepatitis B.
In addition, hospitals and emergency rooms all over the world
use plasma-derived albumin in the treatment of traumatic injuries
such as shock and severe burns.
BioLife
Plasma Services, an affiliate of Baxter Healthcare Corporation,
is one of the largest plasma providers in the world. Through BioLife,
Baxter is committed to providing the highest quality plasma and
plasma services, ensuring a consistent supply of life-saving therapies
to patients.
Glossary Terms:
Intravenous immunoglobulin (IGIV/IGIV):
A treatment for primary immunodeficiency diseases, such as common
variable immunodeficiency, that involves the intravenous administration
of antibodies that have been purified from the plasma of thousands
of healthy donors.